Effect of a rabeprazole half-dose twice daily on acid inhibition in patients with different CYP2C19 alleles.

Published in: European journal of clinical pharmacology (2020)

Rabeprazole 5 mg bid provided no therapeutic advantage for acid inhibition compared with rabeprazole 10 mg qd, regardless of CYP2C19 genotype status.

Keyphrases